NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Alto Neuroscience, Inc. ("Alto" or "the Company") (NYSE:ANRO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants […]

(TSX-V:ELBM),(NASDAQ:ELBM), TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) announces the start of metallurgical testing on cobalt feedstock from two strategic North American sources: the historic Cobalt Camp in Ontario and home to Electra's refinery, and the Company's Iron Creek cobalt and copper project

The Company Delivers Positive Operating Income SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) (“SNDL” or the “Company”) reported its financial and operational results for the secondquarter ended June 30, 2025. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. https://mma.prnewswire.com/media/2741582/SNDL_Inc__SNDL_Reports_Second_Quarter_2025_Financial_and_Operati.jpg SNDL has also posted a supplemental investor presentation

BOSTON, July 31, 2025 (GLOBE NEWSWIRE) — Arcadia(R) (arcadia.io), a leading healthcare data platform, today announced deeper industry collaboration to provide customers with a streamlined pathway into the Centers for Medicare & Medicaid Services' (CMS) Aligned Network Strategy. These efforts will enable Arcadia's customers–including Accountable Care Organizations (ACOs), health systems, and health plans–to connect to

(NASDAQ:KTTA),(NASDAQ:KTTAW), MIAMI, July 31, 2025 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor for the treatment of neurofibromatosis type 1 (NF1) and other MAPK pathway driven indications, today announced the Company has completed enrollment and initial dosing of three subjects

(NASDAQ:BCRX), RESEARCH TRIANGLE PARK, N.C., July 31, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and chief executive officer, Jon Stonehouse, has informed the board of directors of his intention to retire on December 31, 2025. The board has appointed Charlie Gayer, currently the company's chief commercial officer (CCO),

(NASDAQ:ALGM), MANCHESTER, N.H., July 31, 2025 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its first quarter ended June 27, 2025. “We delivered strong first quarter results, with sales of

Enlil, Inc., a Shifamed Portfolio Company and leader in enabling MedTech product innovation, today announced seven new strategic partnerships formed to date in 2025. These agreements, spanning referral, reseller, deployment, and regulatory consulting collaborations, strengthen Enlil's position as a transformative platform in the medical device development ecosystem. https://mma.prnewswire.com/media/2633137/Enlil_Logo.jpg Our shared mission is to simplify the

Led by Avataar Ventures, funding accelerates SAFE's pursuit of cybersecurity superintelligence – while doubling down on its Agentic AI-first approach with the Continuous Threat Exposure Management (CTEM) launch – building on its category-defining leadership in the CRQ and TPRM markets SAFE, the category leader in Cyber Risk Quantification (CRQ) and the first company to deliver

— Former Chief Scientific Officer & President of R&D at Pfizer, Dr. Mikael Dolsten brings decades of R&D and strategic leadership experience in pharmaceutical medicine to guide Marengo's next phase of growth and value creation — World-renowned oncology expert and Director of the Vall d'Hebron Institute of Oncology (VHIO), Dr. Josep Tabernero joins SAB to